Rockefeller Capital Management L.P. Decreases Stake in Avantor, Inc. (NYSE:AVTR)

Rockefeller Capital Management L.P. lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 44.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,079 shares of the company’s stock after selling 20,391 shares during the period. Rockefeller Capital Management L.P.’s holdings in Avantor were worth $649,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Cetera Advisors LLC acquired a new stake in shares of Avantor during the 1st quarter valued at approximately $249,000. SG Americas Securities LLC increased its stake in Avantor by 222.0% in the 2nd quarter. SG Americas Securities LLC now owns 19,996 shares of the company’s stock valued at $424,000 after purchasing an additional 13,786 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Avantor by 2.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after purchasing an additional 733 shares during the last quarter. ORG Partners LLC raised its holdings in Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after purchasing an additional 5,773 shares during the last quarter. Finally, PGGM Investments purchased a new stake in Avantor during the second quarter worth $238,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Avantor stock opened at $22.09 on Tuesday. The stock has a fifty day moving average price of $22.70 and a 200 day moving average price of $23.57. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00. The firm has a market capitalization of $15.03 billion, a P/E ratio of 48.02, a PEG ratio of 2.59 and a beta of 1.29. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on AVTR. UBS Group cut their price target on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Wells Fargo & Company dropped their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Robert W. Baird dropped their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, Barclays reduced their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Avantor currently has a consensus rating of “Moderate Buy” and an average target price of $27.69.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.